deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02397343

The Effect of Hyperbaric Oxygen Therapy on Inflammatory Parameters Induced by a Heat Injury Model (HBO-SHA)

Sponsor: Rigshospitalet, Denmark

Interventions Hyperbaric oxygen
Updated 7 times since 2017 Last updated: Jun 20, 2019 Started: Feb 28, 2015 Primary completion: May 31, 2015 Completion: May 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Inflammation and Secondary Hyperalgesia, this trial is completed. The trial is conducted by Rigshospitalet, Denmark and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotRecruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotUnknown Status~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotUnknown Status~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jul 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown StatusCompleted

  5. Jun 2018 — Jul 2019 [monthly]

    Unknown Status PHASE2

Show 2 earlier versions
  1. May 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    Status: RecruitingUnknown Status

  2. Jan 2017 — May 2017 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rigshospitalet, Denmark
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations